P2RY12 and migraine disorder: The RELIEF trial is an RCT currently undergoing enrollment for P2Y12 inhibitor migraine responsiveness patients with a PFO and randomizing them to PFO closure using GORE Cardioform Septal Occluder or sham procedure.17